In short
Small fibre neuropathy is a condition where damage to tiny nerve fibres causes burning pain, tingling, and numbness, often beginning in the feet and hands. Understanding how this condition is identified can help people seek the right medical care and begin treatment that may improve their quality of life.
Key points
- Standard nerve tests (EMG and nerve conduction studies) usually come back normal in small fibre neuropathy because they only detect large nerve fibre damage, not the tiny fibres that cause symptoms.
- Skin biopsy is the gold standard diagnostic test, measuring the density of small nerve fibres in the outer layer of skin to confirm nerve damage.
- About half of all small fibre neuropathy cases are idiopathic, meaning no underlying cause is found despite thorough testing.
- Diabetes and pre-diabetes are the most common identifiable causes of small fibre neuropathy, making blood sugar testing an essential part of diagnosis.
- Autonomic function testing becomes important when symptoms include dizziness, heart palpitations, digestive problems, or abnormal sweating.
- Clinical trial participation typically requires more rigorous diagnostic confirmation than routine clinical care, almost always including skin biopsy and standardized symptom questionnaires.
- Early diagnosis allows for treatment of underlying causes like diabetes or vitamin deficiencies, which may prevent the nerve damage from progressing further.
- Small fibre neuropathy is not life-threatening, and most people do not develop weakness or balance problems since large nerve fibres remain intact.
Introduction: Who Should Undergo Diagnostics
If you experience persistent burning pain, tingling, or unusual sensations in your feet or hands that feel like pins and needles, it may be time to see a healthcare provider. These symptoms can start gradually and may come and go at first, but they often worsen over time, particularly at night or when you are resting. Many people describe the pain as stabbing, burning, or like an electric shock traveling through their limbs.
Seeking diagnostic testing becomes especially important when you notice other symptoms alongside the pain. Some people develop problems with sweating, either too much or too little. Others experience dizziness when standing up, heart palpitations, stomach problems like cramping or nausea, or changes in bladder or bowel function. These signs suggest that the small nerve fibres controlling automatic body functions may also be affected.
Certain groups of people should be particularly attentive to these symptoms. If you have diabetes or pre-diabetes, you are at higher risk for developing small fibre neuropathy, as elevated blood sugar can damage tiny nerves over time. People with autoimmune diseases such as Sjögren's syndrome, sarcoidosis, or celiac disease should also watch for nerve-related symptoms. Those who have undergone chemotherapy treatment, take certain antibiotics or other medications known to affect nerves, or have a history of excessive alcohol use face increased risk as well.
It is worth noting that about half of all cases of small fibre neuropathy occur without any clear cause, a situation doctors call idiopathic small fibre neuropathy. Even if you cannot identify an obvious reason for your symptoms, diagnostic testing can still confirm whether nerve damage is present and help guide treatment to manage your pain and other symptoms.
Classic Diagnostic Methods
Diagnosing small fibre neuropathy can be challenging because the condition affects nerve fibres so tiny that standard nerve tests often cannot detect the damage. When you visit a healthcare provider with suspected small fibre neuropathy, they will begin with a thorough physical examination and review of your medical history. The doctor will ask detailed questions about your symptoms, when they started, what makes them better or worse, and whether you have any medical conditions or take medications that might contribute to nerve damage.
During the physical examination, the provider will check how well you can feel different sensations. They may test your ability to detect pinpricks, distinguish between hot and cold temperatures, and sense vibration. Unlike other types of nerve damage that affect large nerve fibres, people with small fibre neuropathy typically maintain normal muscle strength, normal reflexes, and normal sense of joint position. If these are abnormal, it suggests that larger nerve fibres may also be involved, which would indicate a different or more advanced type of neuropathy.
One important thing to understand is that standard electromyography, or EMG, and nerve conduction studies usually come back normal in people with small fibre neuropathy. These tests measure the function of large nerve fibres, which control muscle movement and carry certain types of sensation. Because small fibre neuropathy primarily affects the tiny A-delta fibres (lightly myelinated) and C fibres (unmyelinated), which transmit pain, temperature, and autonomic signals, these standard electrical tests miss the problem entirely. Many people with small fibre neuropathy have been told by doctors that their nerves are fine based on these tests, which can lead to frustration and delayed diagnosis.
Skin Biopsy
The most reliable test for confirming small fibre neuropathy is a skin biopsy. This procedure is considered the gold standard for diagnosis. During a skin biopsy, a doctor removes tiny samples of skin, usually from the leg and sometimes from another location on the body. These samples are then examined under a microscope to count the density of small nerve fibres in the outer layer of skin, called the epidermis.
The skin biopsy allows doctors to measure something called intraepidermal nerve fibre density, which simply means how many small nerve fibres are present in a specific area of skin. In people with small fibre neuropathy, this density is reduced compared to what would be expected in someone without nerve damage. The test can detect nerve loss even before symptoms become severe, making it valuable for early diagnosis.
The procedure itself is relatively simple and can often be done in a doctor's office. After numbing the skin with local anesthesia, the doctor uses a small circular punch tool to remove a piece of skin about 3 millimeters in diameter. Most people describe the discomfort as minimal, similar to having blood drawn. The biopsy sites typically heal within a week or two, leaving only small scars.
Autonomic Function Testing
When small fibre neuropathy affects the autonomic nervous system, which controls automatic body functions like heart rate, blood pressure, digestion, and sweating, additional specialized testing may be needed. These tests are particularly useful when people experience symptoms such as dizziness upon standing, rapid heart rate, digestive problems, or abnormal sweating patterns.
One common autonomic test measures how your heart rate and blood pressure respond to changes in position, such as lying down and then standing up. Normally, your body adjusts these automatically to maintain proper blood flow to your brain. People with autonomic small fibre neuropathy may experience a sharp drop in blood pressure when standing, which can cause dizziness, blurred vision, or even fainting.
Another type of autonomic testing evaluates sweating function, called sudomotor function. This is one of the earliest signs of small fibre involvement and can be detected even before other symptoms appear. Various methods can assess sweating, including tests that measure the skin's ability to conduct electricity in response to stimulation, which changes based on sweat gland activity.
Quantitative Sensory Testing
Some healthcare providers use a technique called quantitative sensory testing to measure how well you can detect different sensations. During this test, you will be exposed to carefully controlled levels of heat, cold, vibration, or pressure, and asked to report when you can feel them. The test helps doctors understand the threshold at which you can detect these sensations and whether you have become overly sensitive or less sensitive than normal.
While quantitative sensory testing can provide useful information about nerve function, it has some limitations. The results depend partly on your ability to pay attention and report accurately what you feel, which means factors like fatigue, anxiety, or pain medication can affect the outcome. For this reason, quantitative sensory testing is often used alongside other diagnostic methods rather than as the sole test for small fibre neuropathy.
Blood Tests and Other Investigations
Because many different conditions can cause small fibre neuropathy, your doctor will likely order blood tests to look for underlying causes. These tests serve two purposes: confirming the diagnosis and identifying treatable conditions that might be damaging your nerves. Common blood tests check for diabetes and pre-diabetes by measuring blood sugar levels and hemoglobin A1c. Your doctor may also test for vitamin deficiencies, particularly vitamin B12, which is essential for nerve health.
Additional blood work might screen for thyroid problems, kidney or liver disease, autoimmune disorders, vitamin B6 toxicity, copper deficiency, or signs of immune system abnormalities. If you have symptoms suggesting an infectious cause, tests for HIV, hepatitis C, or Lyme disease may be appropriate. In some cases, testing for genetic mutations in genes like SCN9A or SCN10A, which affect sodium channels in nerve cells, can identify inherited forms of small fibre neuropathy.
Diagnostics for Clinical Trial Qualification
When people with small fibre neuropathy consider participating in research studies or clinical trials, additional diagnostic criteria may apply beyond those used for routine clinical diagnosis. Clinical trials often require very specific and standardized methods to confirm that participants truly have the condition being studied. This ensures that the research results are reliable and can be compared across different groups of patients.
Most clinical trials investigating treatments for small fibre neuropathy will require documentation of the diagnosis through skin biopsy showing reduced intraepidermal nerve fibre density. Trials typically set specific cutoff values below which nerve fibre density must fall for a person to qualify. These thresholds are often compared to normative data that accounts for age, sex, and the location on the body where the biopsy was taken, since nerve density naturally varies based on these factors.
In addition to confirming nerve damage through skin biopsy, clinical trials usually require detailed documentation of symptoms. Researchers may ask participants to complete standardized questionnaires that measure pain intensity, pain quality, and how symptoms affect daily activities and quality of life. These questionnaires help establish baseline symptom severity, which can then be compared to symptoms after treatment to determine whether the intervention being studied is effective.
Some clinical trials may also require autonomic function testing, particularly if the study focuses on treatments for autonomic symptoms. Tests measuring heart rate variability, blood pressure responses to standing, or sweating function might be mandatory for enrollment. This ensures that participants have the specific type of small fibre neuropathy that affects autonomic nerves, if that is what the trial is investigating.
Clinical trials often have strict criteria about what other medical conditions participants can or cannot have. For example, a trial studying treatment for idiopathic small fibre neuropathy might exclude people whose nerve damage is clearly caused by diabetes, chemotherapy, or other identifiable conditions. Conversely, a trial investigating treatment for diabetic neuropathy would require confirmed diabetes diagnosis. Blood tests and medical history reviews help researchers determine whether potential participants meet these eligibility criteria.
It is important to understand that the diagnostic requirements for clinical trial participation are typically more rigorous than those for routine clinical care. While your own doctor might diagnose small fibre neuropathy based on your symptoms and physical examination alone, especially if skin biopsy is not readily available, clinical trials almost always require objective confirmation through biopsy or other standardized testing. This does not mean one approach is better than the other; rather, they serve different purposes. Clinical diagnosis aims to identify people who need treatment, while research diagnosis aims to ensure study participants form a well-defined group that will yield meaningful scientific results.
Prognosis and Survival Rate
Prognosis
Small fibre neuropathy is not a life-threatening condition, and people with this diagnosis have a normal life expectancy. However, the condition can significantly affect quality of life due to chronic pain and other symptoms. The progression of small fibre neuropathy is generally slow, and most people do not develop large nerve fibre involvement over time, meaning muscle weakness and loss of balance typically do not occur.
The course of the disease varies considerably from person to person. Some individuals experience symptoms that remain stable for years, while others notice gradual worsening, particularly if an underlying cause like diabetes is not well controlled. When small fibre neuropathy is caused by a treatable condition such as vitamin B12 deficiency or thyroid disease, addressing that underlying problem can sometimes halt progression or even lead to some improvement in symptoms.
Several factors influence prognosis. People whose neuropathy is caused by well-managed diabetes, corrected vitamin deficiencies, or discontinued toxic medications often have better outcomes than those with idiopathic small fibre neuropathy or neuropathy related to genetic conditions. Early diagnosis and treatment of underlying causes, combined with effective symptom management, generally leads to better quality of life even if the nerve damage itself cannot be completely reversed.
One important complication to be aware of is that small fibre neuropathy affects your ability to sense pain properly. This means you might not notice injuries such as burns, cuts, or pressure sores, particularly on your feet. The condition can also cause dizziness that increases the risk of falls. These complications are manageable with proper precautions, but they underscore the importance of ongoing medical care and self-monitoring.
Survival rate
Small fibre neuropathy itself does not affect survival rates. People with this condition have the same life expectancy as the general population, assuming their underlying conditions are appropriately managed. However, it is important to note that small fibre neuropathy can be a sign of other serious conditions such as diabetes, autoimmune diseases, or vitamin deficiencies. The prognosis for life expectancy depends on these underlying conditions rather than on the nerve damage itself.
While small fibre neuropathy is not life-threatening, the chronic pain and other symptoms can lead to significant psychological distress, including anxiety and depression, which can impact overall well-being. Research has shown that people with small fibre neuropathy often experience reduced quality of life, fatigue, and limitations in daily activities. Addressing these aspects through comprehensive care that includes pain management, psychological support, and lifestyle modifications is essential for maintaining good overall health.
